Coagulopathy Assessment in Patients with COVID-19: A TriNetX Analysis

Basic Details
Date
Tuesday, June 23, 2020
Type
Presentation
Description

This presentation was given at the Reagan-Udall Foundation and Friends of Cancer Research COVID-19 Diagnostics Evidence Accelerator Parallel Analysis meeting by Mayura Shinde from Harvard Pilgrim Health Care Institute on behalf of the FDA Sentinel COVID-19 Coagulopathy workgroup.

Presenter(s)

Mayura Shinde